Psilocybin: clinical potential, mechanistic insights, and biotechnological advances for scalable production.
World journal of microbiology & biotechnology December 31, 2025 José Islas-Vargas, Silvia Armenta, Ángeles Alitzel Rivera-Román et al. 2 citations
Psilocybin, a tryptamine-derived alkaloid from Psilocybe mushrooms, has emerged as a high-value biopharmaceutical candidate due to its promising applications in mental health. While clinical studies highlight its rapid and sustained antidepressant effects, current challenges lie in achieving scalable, reproducible, and cost-effective production to meet growing research and therapeutic demand....